Zentek : Corporate Presentation 2024

Company Overview

NASDAQ: ZTEK

TSX-V:ZEN.V

Q2 2024

Forward Looking Statement

This presentation is being provided for information purposes only and does not constitute or form part of, and should not be construed as, an offer or invitation to sell or any solicitation of any offer to purchase or subscribe for any securities of Zentek Ltd. ("Zentek" or the "Company") in Canada, the United States or any other jurisdiction. Trading in the securities of the Company should be construed as highly speculative. This presentation is not, and in no circumstances is it to be construed as, a prospectus, an offering memorandum, an advertisement, or a public offering of securities. No securities regulatory authority or similar authority has reviewed or in any way passed upon the document or the merits of any securities of the Company and any representation to the contrary is an offence. Except as otherwise stated, information included in this presentation is given as of the date hereof. The delivery of this presentation shall not imply that the information herein is correct as of any date after the date hereof. Each recipient should consult its own investment, legal, tax and other advisers regarding the financial, legal, tax, and other aspects of the Company, including whether it is legally permitted to purchase any securities from the Company under applicable laws. The securities of the Company have not been and may not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or the securities laws of any state of the United States and may not be offered and sold in the United States or to, or for the account or benefit of, U.S. Persons (as such term is defined in Regulation S under the U.S. Securities Act) except pursuant to an exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws or pursuant to a registration statement declared effective by the United States Securities and Exchange Commission .

All dollar amounts referenced herein, unless otherwise indicated, are expressed in US dollars.

No information contained in this presentation constitutes medical advice, and it is not to be used for treatment purposes, or to replace consultation with a qualified medical professional. No information contained herein is intended to diagnose health problems or to take the place of professional medical care. The information contained herein is neither intended to dictate what constitutes reasonable, appropriate or best care for any given health issue, nor is it intended to be used as a substitute for the independent judgment of a physician for any given health issue. All content, including text, graphics, images and information, contained herein is for general information purposes only.

Opinions and estimates disclosed constitute management's judgment and are subject to change without notice, as are any statements of financial market trends, which are based on current market conditions. Management of Zentek does not warrant the accuracy or completeness of the information contained herein.

The presentation may include, in some cases, estimates, projections, forecasts, plans, budgets and similar materials and information regarding or relating to the future operating and financial performance or prospects of Zentek and other anticipated events or results that are not historical facts (collectively, "Forward-Looking Information"). Forward-Looking Information can often be identified by words such as "will", "may", "estimate", "expect", "plan", "project", "intend", "anticipate" and other words indicating that the statements are forward-looking.Forward-Looking Information in this presentation includes, without limitation, estimates and statements with respect to Zentek objectives and goals, to the effect that Zentek or management expects a stated condition or result to occur, regulatory approvals, the adequacy of financial resources, business plans and strategy, and other events or conditions that may occur in the future. All Forward-Looking Information is subject to risks, uncertainties, estimates and assumptions, including the risks described in the Company's public filings with securities commissions or similar regulatory authorities in Canada which are available on the System for Electronic Document Analysis and Retrieval ("SEDAR"). Although the Company has attempted to identify important risks and factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors and risks that cause actions, events or results not to be as anticipated, estimated or intended. Accordingly, there can be no assurance that Forward-Looking Information will be realized. Zentek does not warrant or guarantee the Forward-Looking Information in any way. All of the Forward-Looking Information in this presentation is qualified by these cautionary statements and other cautionary statements or other factors contained herein. Although management of the Company believes that the expectations conveyed by Forward-Looking Information herein are reasonable based on information available on the date such forward-looking statements are made, there can be no assurance that Forward-Looking Information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such Forward-Looking Information. The Company undertakes no obligation to update any Forward-Looking Information, even if new information becomes available as a result of future events or if circumstances or management's estimates or opinions should change or for any other reason, except as required by applicable securities laws. The Forward-Looking Information contained herein is presented for the purposes of assisting readers in understanding the Company's plan, objectives and goals and may not be appropriate for other purposes.

The Forward-Looking Information contained herein was prepared by the management of the Company based on information available at the time the presentation was prepared. Unless otherwise stated, information in this presentation is as of May 6, 2024.

No representation, warranty or guarantee, expressed or implied, is made by Zentek or any of its representatives with respect to the accuracy or completeness of any information provided in this presentation. No person is entitled to rely on the accuracy or completeness of this information. Any third-party information contained herein has not been independently verified. No warranties or representations can be made as to the origin, validity, accuracy, completeness, currency or reliability of the information. The Company disclaims and excludes all liability (to the extent permitted bylaw), for losses, claims, damages, demands, costs and expenses of whatever nature arising in any way out of or in connection with the information in this presentation, its accuracy, completeness or by reason of reliance by any person on any of it. This presentation should not be construed as legal, financial or tax advice to any person. Readers should consult with their own professional advisors regarding their particular circumstances and the Company assumes no liability for any consequences to the investor of any investment in the Company's securities. Neither Zentek, nor its directors, officers, employees, shareholders or agents shall be liable for any claims, expenses, damages (including direct, indirect, special or consequential damages), loss of profits, or opportunities arising from the use of or reliance on the information contained in this presentation.

A Healthier & Safer World

Through Nanotechnology.

Nanotechnology, including graphene, has the potential to protect against pathogens, detect and treat disease, clean our water, make building materials stronger, make products safer

and produce cleaner energy. With
almost limitless potential to improve
people's lives, we are uniquely
positioned to create significant value
through our next-generation solutions.	We develop innovative nanotechnologies with
	our partners to improve people's lives.

One Company; Many Compelling Opportunities

The Growing Indoor Air Quality Market

The indoor air quality (IAQ) market is experiencing robust growth, driven by the increasing post pandemic demand for energy-efficient solutions.

Bioscience & Pharmaceuticals

The bioscience and pharmaceutical market is continuously growing driven by innovations in drug development and a focus on personalized medicine.

EV Revolution & Mineral Asset

The electric vehicle revolution is accelerating, fueled by advancements in battery technology, supportive government policies, and a growing consumer shift towards sustainable transportation options.

Financial Snapshot

	ZTEK	ZEN
Exchange	NASDAQ	TSXV
PPS	$1.09	C$1.51
52 Wk. Range	$0.98- $1.75	C$1.30- C$2.30
Market Cap	~$109.9M	~C$152.2M
Average Daily	~19.9K	~38.0K
Volume
Shares	100.82M
Outstanding

Business Model

Intellectual Property

Secure exclusive rights to our innovative ideas, designs, and unique products

Research & Development

Harness nanotechnology to enhance existing products to solve large-scale problems

Partnerships

Work with manufacturing, distribution, industry professionals and government partners

Go To Market

Bring valuable new solutions to existing markets

Graphene Opportunities

Product Technology Readiness Levels

Enhanced HVAC and PPE Filtration

Q2 2024

Why

Enhanced Air Filters

Could Be the Future of

Air Filtration.

Our Goal:

How it Works

Pathogens

Transmission through airborne aerosols

+

Graphene-Oxide (GO)

Complexed Silver (Ag)

• Hydrophilic (water attracting)
• Efficient carrier of Ag+ ions
• High specific surface area

Highly Synergistic Compound Aimed at

Increasing Viral Filtration Efficiency

Enhanced Protection

Against viruses